Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Investor Presentaiton slide image

Investor Presentaiton

Creation of the Biotechnology Group 2022 TOTAL REVENUE 2022 TOTAL REVENUE Bioprocessing ~$6.2B Research cytiva Bioprocessing 2022 TOTAL REVENUE Bioprocessing + $2.6B Lab & Medical Lab & Medical Research $8.8B PALL ā“‡ Life Sciences cytiva PALL Life Sciences Pie charts reflect FY 2022 revenue by product line. 17 Combination strengthens our leading bioprocessing franchise DANAHER
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube